4D Molecular Therapeutics, Inc. (FDMT)

SEC filing

4D Molecular Therapeutics, Inc.

FDMT · CIK 1650648

4 · Nov 19, 2025 · Bizily Scott sold 1,635 shares at $10.59/share ($17,315); exercised options for 1,635 shares

Bizily Scott sold 1,635 shares at $10.59/share ($17,315); exercised options for 1,635 shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.